Clinical Trials Logo

Acneiform Eruptions clinical trials

View clinical trials related to Acneiform Eruptions.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05120362 Active, not recruiting - Acneiform Eruptions Clinical Trials

A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash

Start date: November 3, 2021
Phase: N/A
Study type: Interventional

Epidermal growth factor receptor inhibitors (EGFRIs) are widely used targeted agents that have been approved for the treatment of various tumor types. In some clinical studies with EGFRIs, the incidence of dermatology AE, the skin rash, is reportedly as high as 95%, which profoundly impact the patients' quality of life. However no treament for onset skin rash has been approved to be effective by any clinical trial yet. Janus kinase (JAK) inhibitor, has been approved for or studied in a variety of skin conditions such as alopecia areata, atopic dermatitis, and psoriasis. Thus the investigators intend to evaluate the efficacy and safety of JAK inhibitor cream for the treatment of EGFRIs-induced skin rash in cancer patients.